These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20390120)

  • 1. [Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations].
    Tincani A; Casu C; Cartella S; Ziglioli T; Cattaneo R
    Reumatismo; 2010; 62(1):65-75. PubMed ID: 20390120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
    Ofer-Shiber S; Molad Y
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
    Roubey RA
    Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
    Raby A; Moffat K; Crowther M
    Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory diagnosis of antiphospholipid syndrome].
    Darnige L
    Rev Med Interne; 2006 Apr; 27(4):296-301. PubMed ID: 16236386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
    Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
    Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
    Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
    Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies.
    De Laat B; Derksen RH; Reber G; Musial J; Swadzba J; Bozic B; Cucnik S; Regnault V; Forastiero R; Woodhams BJ; De Groot PG
    J Thromb Haemost; 2011 Jan; 9(1):149-53. PubMed ID: 20874780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment in patients with antiphospholipid antibodies.
    Bertero M; Kuzenko A
    Minerva Med; 2013 Dec; 104(6):639-48. PubMed ID: 24316917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.